New research published in May indicates a possible connection between B cells and the occurrence of systemic lupus erythematosus symptoms.
Search results for: belimumab
Rheumatology Fellows-in-Training Offer Fresh Perspectives on the ACR/ARHP Annual Meeting
Medical residents relay insights on annual meeting sessions, lectures, networking events, and Boston tourism
Systemic Sjögrens: More Than a Sicca Disease
Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach
Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data
Plus, rheumatology drug news, safety updates
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals
Rheumatology’s premier event to be held in Boston from Nov. 14–19
Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome
Research has led to greater understanding of the disease, potential for better treatment options
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
The State-of-the-Art of Rheumatology Symposium
Experts from across the nation describe the best clinical approaches to rheumatologic disease management.
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- Next Page »